Startups
Cohere Health
Boston, Massachusetts, United States
Cohere Health Inc. is a Boston-based healthcare AI company whose clinical intelligence and operations platform connects health plans and providers across utilization management, prior authorization, payment integrity, appeals, care management and quality measurement. Cohere Unify combines clinician-developed policies with domain-specific machine learning and agentic AI to extract clinical evidence, automate appropriate approvals, guide review and improve workflow coordination. The company says that AI is used to support approvals and that non-approved requests are reviewed by licensed medical professionals; reported approval, savings, ROI and satisfaction metrics are issuer claims, not independently established clinical outcomes. It was incubated with Define Ventures and Humana in2019, with Siva Namasivayam as co-founder and CEO. Its public department pages name21 staff, alongside current and dated executive/medical advisory and corporate board affiliations; this is not a complete700-plus employee directory. The company is relevant to healthcare AI, clinical decision automation and insurance workflow technology, not a documented neural-interface or neuroscience therapeutics developer. It is distinct from Canadian language-model company Cohere/cohere.com, Cohere Technologies, cohere-tech.com and Cohere Capital. Primary financing releases report USD10M Series A July16,2020, an additional USD10M Series A extension in October2020, USD36M Series B April13,2021, USD50M additional equity February1,2024 and USD90M Series C May14,2025. The October2020 own-site date is October22 versus the distributed issuer release October21; the own dated report is used. The2021 release says three months after an Aextension despite the surviving October2020 release: no inventedJanuary2021 additional cash. SEC equity amounts are same-event disclosure snapshots, not extra rounds:36,099,972 in2021;39,999,987 in2024 versus issuer50M event;89,999,876 in2025 versus rounded90M. The issuer’s2025 cumulative200M differs from summed published event values196M; the unexplained difference is not added as an imagined financing. Current medical/governance roles and older dated affiliations are explicitly qualified; directors/advisers are not assumed individual investors.
Founded 2019
Team
 Alaura ShefchikSenior People Business Partner |
 Amir DebourouBoard Director (SEC May2025) |
 Anna WangSoftware Engineer II AI Platform |
 April FurlongCompliance Project Manager |
 Ashleigh MagillAssociate Medical Director, Utilization Management |
 Brian CovinoChief Medical Officer |
Carrie MilbyBoard Director (SEC February2024; current status unverified) |
 Caterina WangSoftware Engineer II |
Cathy FackovecExecutive Vice President and General Manager of Clinical Operations |
 Daniel TorresClinical Training and Quality Specialist |
 Danielle WilliamsRN Reviewer |
 David BarrettBoard Director (SEC May2025) |
Duncan ReeceCo-Founder and Chief Operating Officer (reported2021; current status unverified) |
 Emily BlissMedical Policy Writer |
 Fatima NaqviIntake Specialist |
 Gary L. GottliebExecutive Chair |
 Gigi Yuen-ReedChief Data and AI Officer |
 Jayd KeenerLead RN Reviewer |
 Josh GallatinSenior Strategic Operations Analyst |
Julian HarrisBoard Director (SEC May2025) |
 Kenji FujitaStaff AI Platform Engineer |
Kristen CarucciExecutive Officer (SEC2021–2024; current status unverified) |
 Liana NunziatoSenior Director of Commercial Strategy |
Mark LeenayBoard Director |
 Michael GreeleyBoard Director (SEC May2025) |
 Nicole SaidaiManager of Client & Provider Training and Development |
Paul Johnson (Orthopedic Spine Surgeon)Medical Advisory Board Member (announced April2025) |
 Richard LuProduct Designer |
Robert ShepardsonChief Financial Officer (appointed October2024; SEC officer2025) |
 Ryan HebertClient Support Specialist - L2 Triage |
 Saikrishna JaliparthyLead Software Engineer |
 Sharika GaryReal Time Analyst and Scheduler |
 Siva NamasivayamCo-Founder and Chief Executive Officer · Board Director (SEC May2025) |
Sohail DjaririChief Revenue Officer |
 Tina HuntIntake Specialist |
 Tommy SullySenior Product Manager - AI Platform and Review AI |
William H. ShrankBoard Director (SEC April2021; current status unverified) |
 Zoe LiaoData Scientist II |